Research article  

Functional characterization of the 19q12 amplicon in grade III breast cancers

Rachael Natrajan, Alan Mackay, Paul M Wilkerson, Maryou B Lambros, Daniel Wetterskog, Monica Arnedos, Kai-Keen Shiu, Felipe C Geyer, Anita Langerød, Bas Kreike, Fabien Reyal, Hugo M Horlings, Marc J van de Vijver, Jose Palacios, Britta Weigelt, Jorge S Reis-Filho Breast Cancer Research 2012, 14:R53 (20 March 2012)

Abstract | Full text | PDF | PubMed

Research article  

Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer

Johan Staaf, Göran Jönsson, Markus Ringnér, Bo Baldetorp, Åke Borg Breast Cancer Research 2011, 13:R129 (14 December 2011)

Abstract | Full text | PDF | PubMed

Research article  

Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes

Michael L Gatza, Hsiu-Ni Kung, Kimberly L Blackwell, Mark W Dewhirst, Jeffrey R Marks, Jen-Tsan Chi Breast Cancer Research 2011, 13:R62 (7 June 2011)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research article  

Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics

Göran Jönsson, Johan Staaf, Johan Vallon-Christersson, Markus Ringnér, Karolina Holm, Cecilia Hegardt, Haukur Gunnarsson, Rainer Fagerholm, Carina Strand, Bjarni A Agnarsson, Outi Kilpivaara, Lena Luts, Päivi Heikkilä, Kristiina Aittomäki, Carl Blomqvist, Niklas Loman, Per Malmström, Håkan Olsson, Oskar Th Johannsson, Adalgeir Arason, Heli Nevanlinna, Rosa B Barkardottir, Åke Borg Breast Cancer Research 2010, 12:R42 (24 June 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Editorial  

What do we learn from HER2-positive breast cancer genomic profiles?

Charles Theillet Breast Cancer Research 2010, 12:107 (1 June 2010)

Abstract | Full text | PDF | PubMed